Remdesivir for the Treatment of Covid-19 — Preliminary Report

Share on facebook
Share with friends
Share on twitter
Tweet with friends


Figure 1. Figure 1. Enrollment and Randomization.

Of the 1107 patients who were assessed for eligibility, 1063 underwent randomization; 541 were assigned to the remdesivir group and 522 to the placebo group (Figure 1). Of those…

Others who read this also read

Scroll to Top